会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Process and composition containing pamabrom and pyrilamine maleate
    • 含有马来酸丙胺和吡拉明的方法和组合物
    • US5306507A
    • 1994-04-26
    • US857822
    • 1992-03-26
    • Steven R. Freebersyser
    • Steven R. Freebersyser
    • A61K9/50A61K31/52A61K9/16
    • A61K9/5073A61K31/52
    • A product and process for preparing a pharmaceutical composition for forming tablets, the composition containing pamabrom and pyrilamine maleate. In preferred embodiments, the composition also contains acetaminophen. A fluid bed granulator is charged with a first material containing pamabrom or pyrilamine maleate, and a first liquid containing pregelatinized starch is sprayed onto the first material so as to form a barrier coat. The barrier coated material is dried and then further coated with a second liquid containing only one of pamabrom and pyrilamine maleate, whichever was not present in the first material charged to the fluid bed granulator. The further coated material is then dried to a moisture content of from about 0.5% to less than about 2% by weight, so as to form particles in which the pamabrom and pyrilamine maleate are separated by the pregelatinized starch barrier.
    • 用于制备用于形成片剂的药物组合物的产品和方法,所述组合物含有马来酸马来酸马来酸和马来酸。 在优选的实施方案中,组合物还含有对乙酰氨基酚。 向流化床制粒机中装入含有马来酸马来酸或马来酸吡喃胺的第一种材料,并将含有预胶化淀粉的第一液体喷雾到第一种材料上以形成阻隔涂层。 将阻隔涂层材料干燥,然后进一步用仅含有马来酸马来酸和马来酸吡哆醛之一的第二液体涂覆,以第一种材料中不存在的物质加入到流化床制粒机中。 然后将另外的涂层材料干燥至约0.5重量%至小于约2重量%的水分含量,以便形成其中马来酸马来酸马来酸和吡喃胺类被预胶化淀粉屏障分离的颗粒。
    • 5. 发明授权
    • Compositions of p-hydroxybenzoic acid esters and methods of preparation
and use
    • 对羟基苯甲酸酯的组成及其制备和使用方法
    • US4496576A
    • 1985-01-29
    • US531064
    • 1983-09-12
    • Donald F. LoncriniThomas E. HaagSteven R. Freebersyser
    • Donald F. LoncriniThomas E. HaagSteven R. Freebersyser
    • A01N37/40A01N43/50A01N37/10
    • A01N37/40A01N43/50
    • A composition having broad spectrum antimicrobial activity and being freeze and heat stable is comprised of a clear solution containing up to approximately 90% by weight of a eutectic mixture of three or more lower alkyl esters of p-hydroxybenzoic acid such as isopropyl p-hydroxybenzoate, isobutyl p-hydroxybenzoate and n-butyl p-hydroxybenzoate in a ratio between approximately 1:1:1 to 4:2:2, respectively, approximately 10% to 90% by weight of a "Glydant" solution (composed of 55% 1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin and 45% water) and at least approximately 0.5% by weight based on the weight of the eutectic mixture and the "Glydant" solution of an anionic surfactant. The latter, for example, may be dioctyl sodium sulfosuccinate, sodium lauryl sulfate or the ammonium or sodium salt of sulfated nonylphenoxypoly(ethyleneoxy) ethanol.
    • 具有广谱抗微生物活性并具有冷冻和热稳定性的组合物由含有最多约90重量%的三羟
      基苯甲酸的低级烷基酯如对羟基苯甲酸异丙酯的共晶混合物, 对羟基苯甲酸异丁酯和对羟基苯甲酸正丁酯的比例分别为约1:1:1至4:2:2,约10%至90%重量的“Glydant”溶液(由55%1 ,3-双(羟甲基)-5,5-二甲基乙内酰脲和45%水)和至少约0.5重量%,基于阴离子表面活性剂的共晶混合物和“Glydant”溶液的重量。 后者例如可以是二辛基磺基琥珀酸钠,月桂基硫酸钠或硫酸化壬基苯氧基聚(乙烯氧基)乙醇的铵盐或钠盐。